84549-003-67 : NDC 2026 Code

84549-003-67 : Dantrolene Sodium ( Revonto )

Additionally :

You can get information about “84549-003-67” NDC code in 84549-003-67 in HTML format

HTML | 84549-003-67 in TXT (Plain Text) format

TXT | 84549-003-67 in PDF (Portable Document Format)

PDF | 84549-003-67 in XML format

XML formats.

NDC Code : 84549-003-67 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "84549-003-67",
    "PackageDescription": "60 mL in 1 VIAL, GLASS (84549-003-67) ",
    "NDC11Code": "84549-0003-67",
    "ProductNDC": "84549-003",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Revonto",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Dantrolene Sodium",
    "DosageFormName": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
    "RouteName": "INTRAVENOUS",
    "StartMarketingDate": "20210409",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA078378",
    "LabelerName": "ProPharma Distribution",
    "SubstanceName": "DANTROLENE SODIUM",
    "StrengthNumber": "20",
    "StrengthUnit": "mg/60mL",
    "Pharm_Classes": "Decreased Striated Muscle Contraction [PE], Decreased Striated Muscle Tone [PE], Skeletal Muscle Relaxant [EPC]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2025-12-20",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20250915",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}